Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
62.85 CHF | -10.21% | -13.55% | -14.78% |
07:53am | DOCMORRIS : Gets a Sell rating from UBS | ZD |
May. 16 | DOCMORRIS : Sell rating from UBS | ZD |
Sales 2024 * | 1.18B 1.3B | Sales 2025 * | 1.59B 1.74B | Capitalization | 874M 960M |
---|---|---|---|---|---|
Net income 2024 * | -82M -90.1M | Net income 2025 * | -22M -24.17M | EV / Sales 2024 * | 0.95 x |
Net Debt 2024 * | 251M 276M | Net Debt 2025 * | 282M 310M | EV / Sales 2025 * | 0.73 x |
P/E ratio 2024 * |
-10.5
x | P/E ratio 2025 * |
-41.1
x | Employees | 1,453 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.2% |
Latest transcript on DocMorris AG
1 day | -8.82% | ||
1 week | -11.21% | ||
Current month | -21.33% | ||
1 month | -22.04% | ||
3 months | -25.59% | ||
6 months | +27.95% | ||
Current year | -12.47% |
Managers | Title | Age | Since |
---|---|---|---|
Walter Hess
CEO | Chief Executive Officer | 59 | 14-12-31 |
Founder | 66 | 93-04-05 | |
Marcel Ziwica
DFI | Director of Finance/CFO | 49 | 00-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 10-03-31 | |
Florian Seubert
BRD | Director/Board Member | 51 | 19-05-22 |
Founder | 66 | 93-04-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 746 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +4.49% | - | |
0.00% | 25 M€ | -2.62% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 62.85 | -10.21% | 462 757 |
24-05-17 | 70 | -4.37% | 223,601 |
24-05-16 | 73.2 | +0.48% | 56,330 |
24-05-15 | 72.85 | +0.21% | 73,008 |
24-05-14 | 72.7 | -0.55% | 124,141 |
Delayed Quote Swiss Exchange, May 21, 2024 at 08:38 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.47% | 961M | |
-31.75% | 15.37B | |
-27.24% | 12.7B | |
-26.65% | 6.89B | |
-6.57% | 6.26B | |
+10.76% | 6.2B | |
+75.54% | 4.96B | |
-2.34% | 4.63B | |
-6.60% | 3.98B | |
-9.24% | 3.56B |
- Stock Market
- Equities
- ROSE Stock